Publications by authors named "Arun Tiwari"

94Publications

Genetics of human startle reactivity: A systematic review to acquire targets for an anxiety endophenotype.

World J Biol Psychiatry 2020 Oct 12:1-59. Epub 2020 Oct 12.

Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15622975.2020.1834619DOI Listing
October 2020

Liver enzyme gene and tardive dyskinesia.

Pharmacogenomics 2020 Oct 24;21(15):1065-1072. Epub 2020 Sep 24.

Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2020-0065DOI Listing
October 2020

Preparedness among dental professionals towards COVID-19 in India.

Pan Afr Med J 2020 19;36:108. Epub 2020 Jun 19.

Department of Public Health Dentistry, Sharad Pawar Dental College and Hospital, DMIMS (Deemed to be University), Sawangi, (Meghe) Wardha, Maharashtra, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11604/pamj.2020.36.108.23694DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406455PMC
August 2020

Regulation of melanocortin-4-receptor (MC4R) expression by SNP rs17066842 is dependent on glucose concentration.

Eur Neuropsychopharmacol 2020 Aug 16;37:39-48. Epub 2020 Jul 16.

Pharmacogenetics Research Clinic, Molecular Brain Science, Centre for Addiction and Mental Health, Toronto M5T 1R8, ON, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, M5T 1R8, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario M5T 1R8, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euroneuro.2020.05.008DOI Listing
August 2020

Genome-Wide Association Study of Sleep Disturbances in Depressive Disorders.

Mol Neuropsychiatry 2020 Apr 8;5(Suppl 1):34-43. Epub 2020 Jan 8.

Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000505804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206592PMC
April 2020

Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia.

Drug Dev Res 2020 May 11. Epub 2020 May 11.

Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ddr.21681DOI Listing
May 2020

Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis.

Prog Neuropsychopharmacol Biol Psychiatry 2020 08 23;102:109952. Epub 2020 Apr 23.

Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2020.109952DOI Listing
August 2020

The effect of polymorphisms in startle-related genes on anxiety symptom severity.

J Psychiatr Res 2020 Jun 3;125:144-151. Epub 2020 Apr 3.

Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2020.03.019DOI Listing
June 2020

Association Study of the Complement Component C4 Gene in Tardive Dyskinesia.

Front Pharmacol 2019 26;10:1339. Epub 2019 Nov 26.

Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2019.01339DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901959PMC
November 2019

Towards precision medicine in generalized anxiety disorder: Review of genetics and pharmaco(epi)genetics.

J Psychiatr Res 2019 12 6;119:33-47. Epub 2019 Sep 6.

Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2019.09.002DOI Listing
December 2019

Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.

Schizophr Res 2019 10 22;212:204-212. Epub 2019 Aug 22.

Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2019.07.022DOI Listing
October 2019

Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain.

J Neural Transm (Vienna) 2019 01 18;126(1):27-33. Epub 2018 Sep 18.

Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, R-132, Toronto, ON, M5T1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-018-1921-1DOI Listing
January 2019

BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.

Pharmacogenomics J 2019 06 5;19(3):269-276. Epub 2018 Sep 5.

Psychiatric Neurogenetics Section, Campbell Family Research Institute Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41397-018-0041-5DOI Listing
June 2019

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia.

Neurosci Lett 2018 11 15;686:17-22. Epub 2018 Aug 15.

Neurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science Department, Campbell Family Mental Health Research Institute, CAMH, Canada; Institute of Medical Science, University of Toronto, Canada; Department of Psychiatry, University of Toronto, Canada; Laboratory Medicine and Pathobiology, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://www.sciencedirect.com/journal/neuroscience-letters/v
Web Search
https://academic.oup.com/ntr/article-abstract/11/4/404/11007
Web Search
https://academic.oup.com/schizophreniabulletin/article/21/2/
Web Search
https://linkinghub.elsevier.com/retrieve/pii/S03043940183053
Publisher Site
http://dx.doi.org/10.1016/j.neulet.2018.08.007DOI Listing
November 2018

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia.

Neurosci Lett 2018 11 15;686:17-22. Epub 2018 Aug 15.

Neurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science Department, Campbell Family Mental Health Research Institute, CAMH, Canada; Institute of Medical Science, University of Toronto, Canada; Department of Psychiatry, University of Toronto, Canada; Laboratory Medicine and Pathobiology, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://www.sciencedirect.com/journal/neuroscience-letters/v
Web Search
https://academic.oup.com/ntr/article-abstract/11/4/404/11007
Web Search
https://academic.oup.com/schizophreniabulletin/article/21/2/
Web Search
https://linkinghub.elsevier.com/retrieve/pii/S03043940183053
Publisher Site
http://dx.doi.org/10.1016/j.neulet.2018.08.007DOI Listing
November 2018

Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorder.

Hum Psychopharmacol 2018 07 28;33(4):e2659. Epub 2018 Jun 28.

Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.2659DOI Listing
July 2018

Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study.

Depress Anxiety 2018 10 7;35(10):946-952. Epub 2018 May 7.

Graduate School of Business, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/da.22742
Publisher Site
http://dx.doi.org/10.1002/da.22742DOI Listing
October 2018

Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication.

Psychiatry Res 2019 09 9;279:111-115. Epub 2018 Mar 9.

Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01651781173133
Publisher Site
http://dx.doi.org/10.1016/j.psychres.2018.02.055DOI Listing
September 2019

New findings in pharmacogenetics of schizophrenia.

Curr Opin Psychiatry 2018 05;31(3):200-212

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YCO.0000000000000417DOI Listing
May 2018

Genetics of tardive dyskinesia: Promising leads and ways forward.

J Neurol Sci 2018 06 5;389:28-34. Epub 2018 Feb 5.

Neurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Canada; Department of Psychiatry, University of Toronto, Canada; Institute of Medical Science, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2018.02.011DOI Listing
June 2018

Association study of BDNF and DRD3 genes with alcohol use disorder in Schizophrenia.

Neurosci Lett 2018 04 31;671:1-6. Epub 2018 Jan 31.

Neurogenetics Section, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Canada; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Canada; Institute of Medical Science, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043940183003
Publisher Site
http://dx.doi.org/10.1016/j.neulet.2018.01.033DOI Listing
April 2018

Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT study.

J Psychiatr Res 2018 01 1;96:265-272. Epub 2018 Jan 1.

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Molecular Brain Science Research Department, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2017.09.002DOI Listing
January 2018

A comprehensive analysis of mitochondrial genes variants and their association with antipsychotic-induced weight gain.

Schizophr Res 2017 09 8;187:67-73. Epub 2017 Jul 8.

Neurogenetics Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2017.06.046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660917PMC
September 2017

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain.

Neuropsychobiology 2016 23;74(3):169-175. Epub 2017 May 23.

Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000457903DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653224PMC
February 2018

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.

World J Biol Psychiatry 2019 01 10;20(1):91-95. Epub 2017 Apr 10.

a Neurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science , Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health , Toronto , ON , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15622975.2017.1301681DOI Listing
January 2019

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine.

Mol Neuropsychiatry 2017 Feb 12;2(4):185-197. Epub 2016 Oct 12.

Neuroscience Research Department, Campbell Family Research Institute, Toronto, Ont., Canada; Institute of Medical Science, Toronto, Ont., Canada; Department of Psychiatry, University of Toronto, Toronto, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000449224DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318922PMC
February 2017

Association study between the neurexin-1 gene and tardive dyskinesia.

Hum Psychopharmacol 2017 01;32(1)

Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.2568DOI Listing
January 2017

Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.

Am J Psychiatry 2017 05 10;174(5):468-475. Epub 2017 Jan 10.

From the Institute of Medical Science, University of Toronto, Toronto; the Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto; the Department of Psychiatry, McGill University, Montreal; the Department of Psychiatry and the Department of Pharmacology, University of Toronto, Toronto; the Department of Psychiatry, University of Pittsburgh, Pittsburgh; the Geriatric Research Education and Clinical Center, VA Pittsburgh Health System, Pittsburgh; and the Healthy Mind Lab, Department of Psychiatry, Washington University, St. Louis.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2016.16050617DOI Listing
May 2017

DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.

Neurosci Lett 2018 03 4;669:14-23. Epub 2017 Jan 4.

Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043940163101
Publisher Site
http://dx.doi.org/10.1016/j.neulet.2016.12.071DOI Listing
March 2018

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain.

World J Biol Psychiatry 2018 15;19(sup3):S97-S105. Epub 2016 Dec 15.

a Neurogenetics Section, Neuroscience Department , Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health , Toronto , ON , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15622975.2016.1262061DOI Listing
September 2019

Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.

Brain 2016 07 13;139(Pt 7):2050-62. Epub 2016 May 13.

4 Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Canada 5 Institute of Medical Science, University of Toronto, Toronto, Canada 7 Department of Psychiatry, University of Toronto, Toronto, Canada 8 Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada 11 Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada 12 Lancaster Medical School and Data Science Institute, Lancaster University, Lancaster, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/aww109DOI Listing
July 2016

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.

Hum Psychopharmacol 2016 Mar 15;31(2):121-34. Epub 2016 Feb 15.

Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.2519DOI Listing
March 2016

Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.

Int J Neuropsychopharmacol 2016 05 29;19(5). Epub 2016 Apr 29.

Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada (Mr Huang, Dr Zai, Ms Lisoway, Dr Maciukiewicz, Mr Felsky, Dr Tiwari, Dr Müller, and Dr Kennedy); Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN (Dr Bishop); Department of Psychiatry, Fujita Health University, Toyoake, Aichi, Japan (Dr Ikeda); Departamento de Psiquiatria, Clinica Universidad de Navarra, Pamplona, Spain (Drs Molero and Ortuno); Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy (Dr Porcelli); Department of Psychiatry, Pomeranian Medical University, Szczecin, Poland (Dr Samochowiec); Department of Pharmacology, Institute of Psychiatry and Neurology, Warsaw, Poland (Dr Mierzejewski); Department of Psychiatry, Ningbo Kangning Hospital, Ningbo, China (Dr Gao); Department of Psychiatry, CIBERSAM, University Hospital Marqués de Valdecilla- IDIVAL, School of Medicine, University of Cantabria, Santander, Spain (Dr Pelayo-Terán); Institute of Genomics and Integrative Biology, Delhi, India (Drs Kaur and Kukreti); Feinberg School of Medicine, Northwestern University, Chicago, IL (Dr Meltzer); Department of Psychiatry, Columbia University Medical Center, New York, NY (Dr Lieberman); Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA (Dr Potkin).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ijnp/pyv132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886669PMC
May 2016

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.

Pharmacogenomics 2016 15;17(2):103-9. Epub 2015 Dec 15.

250 College Street, Pharmacogenetic Research Clinic, Centre for Addiction & Mental Health, Toronto, ON, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.15.155DOI Listing
September 2016

The Role of the Catechol-o-Methyltransferase (COMT) GeneVal158Met in Aggressive Behavior, a Review of Genetic Studies.

Curr Neuropharmacol 2015 ;13(6):802-14

Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario M5T 1R8 Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759319PMC
http://dx.doi.org/10.2174/1570159x13666150612225836DOI Listing
September 2016

Corrigendum to "Age at onset of schizophrenia: Cannabis, COMT gene, and their interactions" [Volume 151, Issues 1-3, December 2013, Pages 289-290].

Schizophr Res 2015 Dec 14;169(1-3):507. Epub 2015 Nov 14.

Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2015.09.031DOI Listing
December 2015

Genetic variation in IL-1β, IL-2, IL-6, TSPO and BDNF and response to duloxetine or placebo treatment in major depressive disorder.

Pharmacogenomics 2015 Nov 10;16(17):1919-29. Epub 2015 Nov 10.

Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, 250 College Street, Toronto, ON M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.15.136DOI Listing
November 2015

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain.

World J Biol Psychiatry 2016 04 8;17(3):221-9. Epub 2015 Oct 8.

a Pharmacogenetics Research Clinic, Neurogenetics Section , Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health , Toronto , ON , Canada .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/15622975.2015.1076173DOI Listing
April 2016

Physicians' opinions following pharmacogenetic testing for psychotropic medication.

Psychiatry Res 2015 Oct 7;229(3):913-8. Epub 2015 Aug 7.

Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2015.07.032DOI Listing
October 2015

Physicians' opinions following pharmacogenetic testing for psychotropic medication.

Psychiatry Res 2015 Oct 7;229(3):913-8. Epub 2015 Aug 7.

Pharmacogenetic Research Clinic, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2015.07.032DOI Listing
October 2015

Pharmacogenetics and outcome with antipsychotic drugs.

Dialogues Clin Neurosci 2014 Dec;16(4):555-66

Pharmacogenetics Research Clinic, Campbell Family Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336924PMC
December 2014

The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain.

World J Biol Psychiatry 2015 Jan;16(1):45-56

Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health & Department of Psychiatry, University of Toronto , Toronto, ON , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/15622975.2014.984631DOI Listing
January 2015

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain.

J Clin Psychopharmacol 2015 Feb;35(1):7-12

From the *Neurogenetics Section, Centre for Addiction and Mental Health; †Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; ‡Department of Psychiatry and Psychotherapy, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; §Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, Lieber Center for Schizophrenia Research, New York Presbyterian Hospital & Columbia University Medical Center, New York, NY; and ║Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000261DOI Listing
February 2015

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain.

J Clin Psychopharmacol 2015 Feb;35(1):7-12

From the *Neurogenetics Section, Centre for Addiction and Mental Health; †Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; ‡Department of Psychiatry and Psychotherapy, Campus Mitte, Charité Universitätsmedizin Berlin, Berlin, Germany; §Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, Lieber Center for Schizophrenia Research, New York Presbyterian Hospital & Columbia University Medical Center, New York, NY; and ║Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000261DOI Listing
February 2015

Genetic variation in CYP3A43 is associated with response to antipsychotic medication.

J Neural Transm (Vienna) 2015 Jan 24;122(1):29-34. Epub 2014 Aug 24.

Pharmacogenetics Research Clinic, Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, 250 College Street, Toronto, ON, M5T1R8, Canada,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-014-1298-8DOI Listing
January 2015

No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gain.

Psychiatry Res 2014 Oct 28;219(2):255-60. Epub 2014 May 28.

Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01651781140040
Publisher Site
http://dx.doi.org/10.1016/j.psychres.2014.05.031DOI Listing
October 2014

Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.

Hum Psychopharmacol 2014 Jul 16;29(4):330-5. Epub 2014 Apr 16.

Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hup.2407
Publisher Site
http://dx.doi.org/10.1002/hup.2407DOI Listing
July 2014

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain.

Pharmacogenomics 2014 Mar;15(4):423-31

Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction & Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/pgs.13.247
Publisher Site
http://dx.doi.org/10.2217/pgs.13.247DOI Listing
March 2014

Investigation of melanocortin system gene variants in antipsychotic-induced weight gain.

World J Biol Psychiatry 2014 Apr 24;15(3):251-8. Epub 2014 Feb 24.

Neurogenetics Section, Neuroscience Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health , Toronto, ON , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/15622975.2013.858827DOI Listing
April 2014

Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study.

Neuropsychobiology 2014 30;69(1):59-63. Epub 2014 Jan 30.

Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000356231DOI Listing
January 2015

Age at onset of schizophrenia: cannabis, COMT gene, and their interactions.

Schizophr Res 2013 Dec 20;151(1-3):289-90. Epub 2013 Nov 20.

Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2013.10.037DOI Listing
December 2013

A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.

Neuropsychopharmacology 2014 May 7;39(6):1347-54. Epub 2013 Nov 7.

1] Department of Psychiatry, University of Toronto, Toronto, ON, Canada [2] Neuroscience Section, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npp.2013.312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988538PMC
May 2014

Role of synaptosome-related (SNARE) genes in adults with attention deficit hyperactivity disorder.

Psychiatry Res 2014 Mar 28;215(3):799-800. Epub 2013 Oct 28.

Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2013.06.025DOI Listing
March 2014

Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.

Hum Psychopharmacol 2013 Mar 30;28(2):183-7. Epub 2013 Jan 30.

Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hup.2288
Publisher Site
http://dx.doi.org/10.1002/hup.2288DOI Listing
March 2013

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

J Clin Psychopharmacol 2013 Feb;33(1):11-7

Neurogenetics Section, Neuroscience Department, Centre forAddiction and Mental Health & Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0b013e31827d145aDOI Listing
February 2013

Analysis of 34 candidate genes in bupropion and placebo remission.

Int J Neuropsychopharmacol 2013 May 4;16(4):771-81. Epub 2012 Sep 4.

Neurogenetics Section, Neuroscience Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1461145712000843DOI Listing
May 2013

The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism.

Genet Test Mol Biomarkers 2012 Aug 9;16(8):897-903. Epub 2012 Jul 9.

Pharmacogenetics Research Clinic, Neurogenetics Section, Department of Psychiatry, Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/gtmb.2011.0327DOI Listing
August 2012

Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia.

Cereb Cortex 2013 Sep 6;23(9):2044-57. Epub 2012 Jul 6.

Kimel Family Translational Imaging-Genetics Laboratory, Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cercor/bhs188DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729194PMC
September 2013

The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain.

Prog Neuropsychopharmacol Biol Psychiatry 2012 Oct 27;39(1):96-101. Epub 2012 May 27.

Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, ON M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2012.05.014DOI Listing
October 2012

DRD4 VNTR polymorphism and age at onset of severe mental illnesses.

Neurosci Lett 2012 Jun 20;519(1):9-13. Epub 2012 Apr 20.

Neurogenetics Section, Neuroscience Department, Centre for Addiction and Mental Health, Toronto, ON, Canada. vanessa

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2012.04.027DOI Listing
June 2012

DRD4 VNTR polymorphism and age at onset of severe mental illnesses.

Neurosci Lett 2012 Jun 20;519(1):9-13. Epub 2012 Apr 20.

Neurogenetics Section, Neuroscience Department, Centre for Addiction and Mental Health, Toronto, ON, Canada. vanessa

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2012.04.027DOI Listing
June 2012

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.

J Psychiatr Res 2012 Apr 2;46(4):462-8. Epub 2012 Feb 2.

Neurogenetics Section, Neuroscience Department, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2012.01.010DOI Listing
April 2012

Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.

Prog Neuropsychopharmacol Biol Psychiatry 2012 Apr 8;37(1):62-75. Epub 2011 Dec 8.

Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2011.11.018DOI Listing
April 2012

The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.

Schizophr Res 2011 Nov 3;132(2-3):121-4. Epub 2011 Sep 3.

Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2011.08.007DOI Listing
November 2011

The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.

Schizophr Res 2011 Nov 3;132(2-3):121-4. Epub 2011 Sep 3.

Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2011.08.007DOI Listing
November 2011

Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain.

Hum Psychopharmacol 2011 Aug 8;26(6):386-91. Epub 2011 Aug 8.

Neurogenetics Section, Centre for Addictions and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.1219DOI Listing
August 2011

ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype.

World J Biol Psychiatry 2011 Aug 18;12(5):392-7. Epub 2011 Jul 18.

Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/15622975.2011.564655DOI Listing
August 2011

The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychoses.

Neuropsychopharmacology 2011 Aug 27;36(9):1871-8. Epub 2011 Apr 27.

Department of Psychiatry, Centre for Addiction and Mental Health, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/npp201172
Publisher Site
http://dx.doi.org/10.1038/npp.2011.72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154105PMC
August 2011

Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response.

Pharmacogenomics 2011 Feb;12(2):277-91

Neurogenetics Section, Centre for Addiction & Mental Health, 250 College Street, Toronto, Ontario, 5T1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.10.182DOI Listing
February 2011

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis.

Pharmacogenomics 2010 Nov;11(11):1561-71

Neurogenetics Section, Centre for Addiction & Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.10.123DOI Listing
November 2010

Genetics in schizophrenia: where are we and what next?

Dialogues Clin Neurosci 2010 ;12(3):289-303

Neurogenetics section, Neuroscience department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181975PMC
November 2010

Weak association of the platelet-derived growth factor beta (PDGFB) and PDGF receptor beta (PDGFRB) genes with schizophrenia and schizoaffective disorder.

World J Biol Psychiatry 2011 Mar 18;12(2):127-33. Epub 2010 Oct 18.

Neurogenetics Section, Centre for Addiction and Mental Health, Clarke Division, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/15622975.2010.520333DOI Listing
March 2011

Variation in calcium and magnesium ratio with increasing electrical conductivity of groundwater from shallow basaltic aquifers of Maharashtra (India).

J Environ Sci Eng 2010 Oct;52(4):311-4

Central Ground Water Board (CGWB), Central Region, Civil Lines, Nagpur-440 001, Maharashtra, India.

View Article

Download full-text PDF

Source
October 2010

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients.

Prog Neuropsychopharmacol Biol Psychiatry 2010 Dec 20;34(8):1484-90. Epub 2010 Aug 20.

Neurogenetics Section, Neuroscience Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2010.08.009DOI Listing
December 2010

Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.

Pharmacogenomics 2010 Jun;11(6):773-80

Department of Psychiatry & Psychotherapy, Charité University Medicine Berlin, Campus Benjamin Franklin, Eschenallee 3, 14050 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.10.50DOI Listing
June 2010

The intersection of pharmacology, imaging, and genetics in the development of personalized medicine.

Dialogues Clin Neurosci 2009 ;11(4):363-76

Centre for Addiction and Mental Health, University of Toronto, Canada.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181934PMC
March 2010

Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.

Prog Neuropsychopharmacol Biol Psychiatry 2010 Feb 22;34(1):50-6. Epub 2009 Sep 22.

Neurogenetics Section, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada M5T 1R8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2009.09.020DOI Listing
February 2010

Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia.

Schizophr Res 2009 Oct 13;114(1-3):33-8. Epub 2009 Aug 13.

Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2009.07.010DOI Listing
October 2009

Pharmacogenetics of anxiolytic drugs.

J Neural Transm (Vienna) 2009 Jun 12;116(6):667-77. Epub 2009 May 12.

Neurogenetics Section, Centre for Addiction and Mental Health, 250 College Street, R-30, Toronto ONM5T1R8, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00702-009-0229-6
Publisher Site
http://dx.doi.org/10.1007/s00702-009-0229-6DOI Listing
June 2009